NCI Dictionary of Cancer Terms
The search textbox has an autosuggest feature. When you enter three or more characters, a list of up to 10 suggestions will popup under the textbox. Use the arrow keys to move through the suggestions. To select a suggestion, hit the enter key. Using the escape key closes the listbox and puts you back at the textbox. The radio buttons allow you to toggle between having all search items start with or contain the text you entered in the search box.
A drug that was used to treat acute myeloid leukemia (AML) that recurred (came back). It was used in older patients who were not able to take other anticancer drugs. Mylotarg was taken off the market but continues to be studied in clinical trials for the treatment of certain types of leukemia. It contains a monoclonal antibody that binds to a protein called CD33, which is found on some leukemia cells. It also contains a toxic substance, which may help kill cancer cells. Mylotarg is a type of antibody-drug conjugate. Also called gemtuzumab ozogamicin.